Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-24-018379

Chief Financial Officer sold 1,000 shares at $209.81 ($209,810)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Sandercock Brett · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-06-10 Sale : show line 1 in the form 10b5-1 −1,000 $209.81 $209,810 91,056 D
Open-market sales · 1,000 sh · avg $209.81 · $209,810
Loading xslF345X05/form4.xml…